[HTML][HTML] Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study
A Couttenier, O Lacroix, G Silversmit, E Vaes… - Cancer …, 2019 - Elsevier
Background Preclinical studies suggest that β-blockers could exhibit anticancer properties in
ovarian cancer. Similar effects have also been reported in observational studies, but their
results remain inconsistent and could be impaired by methodological limitations. This study
aimed to investigate whether β-blocker use is associated with improved survival in ovarian
cancer patients at the Belgian population level. Methods We conducted a population-based
study by linking data of the Belgian Cancer Registry with medical claims data of the health …
ovarian cancer. Similar effects have also been reported in observational studies, but their
results remain inconsistent and could be impaired by methodological limitations. This study
aimed to investigate whether β-blocker use is associated with improved survival in ovarian
cancer patients at the Belgian population level. Methods We conducted a population-based
study by linking data of the Belgian Cancer Registry with medical claims data of the health …
